RecruitingNCT07468201

Development of an Innovative Method to Extract Cord Blood Stem Cells With High Efficiency


Sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia

Enrollment

12 participants

Start Date

Apr 10, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The present study has the purpose to develop an innovative method for obtaining HSCs with a high yield. HSCs extracted from UCB using the traditional method followed by several steps of centrifugation will be compared to the new method which exploit a new biocompatible liquid, capable to separate the HSCs without causing mechanical stress to cells. The potential of ozone treatment to stimulate cells proliferation will be also assessed. Since ozone has been identified as an adjuvant to sustain cytoprotective pathways increasing cell performance, HSCs obtained from UCB samples will be treated by flowing ozone at low concentrations (between 2 and 20 μg/mL) in a mixture 1:1 with oxygen.


Eligibility

Sex: FEMALE

Inclusion Criteria1

  • Healthy women who have signed the informed consent for umbilical cord donation for research purposes

Exclusion Criteria1

  • Women with inability to comply with the requirements of the protocol and presence of viral infections.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERUmbilical cord blood collection

the study purpose is to collect between 70 to 200 ml of blood for each donor from both caesarean and natural births, post-partum. The umbilical cord will be clamped, as directed by the surgeon performing the procedure, in two places: close to the placenta and close to the baby.


Locations(1)

Fondazione IRCCS Policlinico San Matteo di Pavia

Pavia, Lombardy, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07468201